PARABOLIC DRUGS (India) Risk Analysis And Volatility

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:4em;padding-top: 25px;;'>PA</div>
Our approach into forecasting volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for PARABOLIC DRUGS which you can use to evaluate future volatility of the entity. Please check PARABOLIC DRUGS to confirm if risk estimate we provide are consistent with the epected return of 0.0%.

PARABOLIC DRUGS Technical Analysis

We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

PARABOLIC DRUGS Projected Return Density Against Market

Assuming 30 trading days horizon, PARABOLIC DRUGS has beta of 0.0 . This implies the returns on DOW and PARABOLIC DRUGS do not appear to be sensible. Furthermore, It does not look like the company alpha can have any bearing on the equity current valuation.
Assuming 30 trading days horizon, the coefficient of variation of PARABOLIC DRUGS is 0.0. The daily returns are destributed with a variance of 0.0 and standard deviation of 0.0. The mean deviation of PARABOLIC DRUGS is currently at 0.0. For similar time horizon, the selected benchmark (DOW) has volatility of 0.78
Alpha over DOW
Beta against DOW=0.00
Overall volatility
Information ratio =0.00

PARABOLIC DRUGS Return Volatility

the enterprise accepts 0.0% volatility on return distribution over the 30 days horizon. the entity inherits 0.8011% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 

PARABOLIC DRUGS Investment Opportunity

DOW has a standard deviation of returns of 0.8 and is 9.223372036854776E16 times more volatile than PARABOLIC DRUGS. of all equities and portfolios are less risky than PARABOLIC DRUGS. Compared to the overall equity markets, volatility of historical daily returns of PARABOLIC DRUGS is lower than 0 () of all global equities and portfolios over the last 30 days.

PARABOLIC DRUGS Current Risk Indicators

PARABOLIC DRUGS Suggested Diversification Pairs

Check out Your Equity Center. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Company logos by clearbit